Diagnosis, Treatment, and Outcome Assessment of Septic Cardiomyopathy Using an Integrated Mathematical Model
Key facts
- Who runs it
- Vilnius University
- Where
- Lithuania and Poland2 sites in 2 countriesChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 17 Mar 2024
- Expected to end
- Mar 2028
- Type of study
- Observational
- Record updated
- 27 January 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (16)Hide the full registry criteria
Who can take part
- Age 18 years or older
- Sepsis according to SEPSIS-3 criteria:
- Suspected/confirmed infection and
- SOFA (Sequential Organ Failure Assessment) score ≥ 2 or qSOFA score ≥ 2
- Septic shock according to SEPSIS-3 criteria:
- Sepsis is diagnosed and
- Vasopressor infusion is used to maintain a mean arterial pressure (MAP) ≥ 65 mmHg and
- Lactate \> 2 mmol/l
- Cardiovascular support requirement for norepinephrine \> 0.1 mcg/kg/min infusion
- Signed informed consent form (ICF)
Who cannot take part
- Has uncompensated cardiovascular disease:
- Congenital heart disease
- Heart failure NYHA functional class IV
- Individuals under 18 years of age
- Cardiogenic shock
- Refusal to participate in the study
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Septic cardiomyopathy
This trial is currently available in Lithuania and Poland.
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this observational study is to evaluate whether a new integrated mathematical model can improve the accuracy of diagnosing septic cardiomyopathy and predicting clinical outcomes in adult patients with suspected septic cardiomyopathy. The study aims to determine whether the integrated mathematical model enhances diagnostic accuracy and improves the prediction of clinical outcomes in these patients.
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Use of an Integrated Mathematical Model for the Diagnosis, Treatment and Outcome Assessment of Septic Cardiomyopathy
- Criteria questions
- Built from NCT06793020, who can take part
- Record updated
- 27 January 2025